COMP <GO>
LNN vs TMO // FREE CASH FLOW YIELD
Lindsay Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: LNN 8
— TMO 4
▲ FREE CASH FLOW YIELD LEADER: LNN
LAST: $106.38 (+2.91%) • MKT CAP: $1.08B
fcf-yield
8.36%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
fcf-yield
2.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LNN VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LNN | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.10% | 9.30% | +6.80 | LNN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 8.0x | 30.4x | -22.40 | LNN | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 8.36% | 2.40% | +5.96 | LNN | /fcf-yield <GO> |
| Operating Margin | 13.40% | 17.40% | -4.00 | TMO | /operating-margins <GO> |
| Net Profit Margin | 11.20% | 15.10% | -3.90 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 12.80% | 3.90% | +8.90 | LNN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.46% | 0.24% | +1.22 | LNN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.04 | 4.50 | +0.54 | LNN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | LNN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.2 | 62.9 | -17.71 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 12.3x | 36.3x | -24.00 | LNN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.08B | $262.22B | -$261.14B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LNN REV | TMO REV | LNN GROSS % | TMO GROSS % | LNN FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $659.1M | $44.56B | 32.0% | — | $90.4M | $6.29B |
| FY 2024 | $584.3M | $42.88B | 32.7% | — | $66.8M | $7.27B |
| FY 2023 | $661.9M | $42.86B | — | — | $119.7M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LNN // BETA —
TMO // BETA 0.94